What's breaking now, across thousands of outlets.
Eli Lilly is looking to get into the aesthetics business and acquire drugs that could treat skin aging and diseases, body shape and hair conditions, according to a new job posting. The
We haven't written up this one. Endpoints News has the full story — the link below goes straight to it.
(MedPage Today) -- Hypofractionated postmastectomy radiotherapy continued to provide locoregional control for patients with high-risk breast cancer, 10-year data from a phase III trial showed.
The study reveals a subtle change in how children view faces that may signal growing depression risk before adolescence.
He said the scale of deaths meant that AMR should no longer be treated as a “silent pandemic”, stressing that “we know what works” to prevent and control the threat.
Falls kill thousands of older Americans each year. One expert argues the U.S. needs clearer, more consistent floor testing.
Eli Lilly and Novo are developing new amylin drugs that serve as another biological lever to pull in treating obesity and diabetes.
Eli Lilly and Novo are developing new amylin drugs that serve as another biological lever to pull in treating obesity and diabetes.
